COMMUNIQUÉS West-GlobeNewswire

Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs

13/03/2025 - 14:00

The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable and accelerate the [...]

Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial

13/03/2025 - 14:15

LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranovia™. The trial [...]

FDA Issues Clearance for ReWalk 7 Exoskeleton

13/03/2025 - 14:15

Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd [...]

Aclarion Provides Shareholder Update

13/03/2025 - 14:25

BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW) , a healthcare technology company that is leveraging biomarkers and proprietary augmented [...]

Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office

13/03/2025 - 14:30

Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, today announced the [...]

EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs)

13/03/2025 - 14:34

EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs) Findings in HIV highlight AMV technology's versatility, robust immune response, and [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

13/03/2025 - 15:45

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 13 March 2025 at 16.45 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

MEDIA ADVISORY: Ontario Health Coalition shocked and disappointed with court rulings in Bill 7 Charter Challenge and Orchard Villa case; vows to continue the fight to protect the rights of the elderly

13/03/2025 - 16:55

TORONTO, March 13, 2025 (GLOBE NEWSWIRE) -- In a press conference this morning, the Ontario Health Coalition responded to court rulings in two cases impacting thousands of elderly hospital patients and long-term care [...]

PALTmed & LTC ACO Launch Value-Based Care Joint Alliance

13/03/2025 - 17:00

Collaboration aims to encourage and empower long-term care providers’ participation in value-based care KENNETT SQUARE, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- Post-Acute and Long-Term Care Medical Association (PALTmed [...]

Pills2Me Reaches One Million Prescription Deliveries Milestone and Announces Nationwide Launch

13/03/2025 - 17:30

LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- Pills2Me, the rapidly growing on-demand prescription delivery service, today announced its nationwide rollout, set to begin in Q2 of 2025. This ambitious expansion follows a [...]

VIRBAC: Résultats 2024

13/03/2025 - 17:45

Chiffre d’affaires en très forte progression de 13,6% à taux de change constant tirée par : une croissance organique dynamique (+7,5%) l’apport stratégique de nos acquisitions (+6,1%) Un résultat opérationnel 2 2024 à [...]

Virbac: 2024 Annual results

13/03/2025 - 17:45

Very strong revenues increase of 13.6% at constant exchange rates, driven by: dynamic organic growth (+7.5%) strategic contribution of our acquisitions (+6.1%) 2024 operating income 2 at an all-time high of 16.6% of [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2025

13/03/2025 - 17:45

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]

EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 12 mars 2025

13/03/2025 - 18:00

Nombre total de droits de vote et d’actions composant le capital social au 12 mars 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 12, 2025

13/03/2025 - 18:00

Disclosure of Share Capital and Voting Rights Outstanding as of March 12, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Annual General Meeting in ALK-Abelló A/S held on 13 March 2025

13/03/2025 - 18:06

ALK ( ALKB:DC / OMX: ALK B / AKBLF ): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025. The Annual General Meeting transacted the following business: Approval of the annual report 2024 and discharge of [...]

Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2024

13/03/2025 - 18:45

Communiqué de mise à disposition des comptes consolidés au 31 décembre 2024. Le Groupe annonce avoir mis à la disposition du public ses comptes consolidés au 31 décembre 2024 sur le site internet du Groupe, à l’adresse [...]

Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2024

13/03/2025 - 18:45

Public release of Virbac Consolidated Accounts at 31 December 2024. The Group released its 2024 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com, under “Investors”, “ [...]

Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors

13/03/2025 - 21:00

Dr. Baynes has been a member of Nurix’s Medical Advisory Board since 2023 SAN FRANCISCO, March 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on [...]